Understanding brain tumours: A comprehensive guide

Written in association with: Dr Paul Mulholland
Published:
Edited by: Aoife Maguire

Receiving a diagnosis of a brain tumour can be a daunting and overwhelming experience. In this article, leading consultant medical oncologist Dr Paul Mulholland aims to provide you with a comprehensive understanding of brain tumours, from their types and symptoms to diagnosis and treatment options.

 

 

What is a brain tumour?

 

A brain tumour is an abnormal growth of cells in the brain. These cells can either be cancerous (malignant) or non-cancerous (benign). Benign tumours are usually slow-growing and unlikely to spread to other parts of the body. However, they can still cause problems by putting pressure on surrounding brain tissue. Malignant tumours, on the other hand, can grow rapidly and invade nearby tissues, posing a greater risk to health.

 

What are the different types of brain tumours?

 

Brain tumours can arise from different types of cells in the brain, leading to various classifications. Some common types include meningiomas, gliomas, and pituitary tumours. Meningiomas originate from the membranes surrounding the brain and spinal cord, while gliomas develop from the supportive tissue of the brain. Pituitary tumours, as the name suggests, arise from the pituitary gland, which plays a crucial role in regulating hormone levels in the body.

 

What are the symptoms?

 

The symptoms of a brain tumour can vary depending on its size, location, and growth rate. Common symptoms may include persistent headaches, seizures, changes in vision or hearing, difficulty speaking or understanding language, and changes in personality or behaviour. It should be noted that these symptoms may be caused by other conditions, therefore it is crucial to consultant an oncologist for an accurate diagnosis.

 

Diagnosis

 

Diagnosing a brain tumour typically involves a combination of imaging tests, such as MRI or CT scans, and a biopsy, where a small sample of the tumour is removed and examined under a microscope. These tests help determine the type, size, and location of the tumour, which are crucial factors in developing an effective treatment plan.

 

Treatment options

 

Treatment for brain tumours may vary depending on several factors, including the type and stage of the tumour, as well as the patient's overall health and preferences. Common treatment options include surgery, radiation therapy, and chemotherapy. In some cases, a combination of these treatments may be used to achieve the best possible outcome.

 

Receiving a diagnosis of a brain tumour can be overwhelming, but it's essential to remember that you're not alone. There are various treatment options available, and with the support of healthcare professionals and loved ones, many individuals are able to manage their condition and lead fulfilling lives. If you have any concerns or questions about brain tumours, don't hesitate to reach out to your doctor for guidance and support.

 

 

 

If you would like to book a consultation with Dr Mulholland, do not hesitate to do so by visiting his Top Doctors profile today

By Dr Paul Mulholland
Medical oncology

Dr Paul Mulholland is a highly experienced consultant medical oncologist based in London. He exclusively treats brain cancer, specialising in brain tumours, metastasis, neuroendocrine tumours, immunotherapy and clinical trials.
 
He serves as a consultant at University College Hospital, the National Hospital for Neurology and Neurosurgery (part of UCLH), and Mount Vernon Cancer Centre. Additionally, he chairs the HCA Cancer Care brain and CNS tumour board.
 
Dr. Mulholland holds the position of honorary senior lecturer at University College London and serves as a training programme director. His doctoral research at the Cancer Research UK London Research Institute focused on genomic profiling in brain cancer, laying the foundation for his work on biomarkers and therapy targets in this field. He currently oversees a clinical trial portfolio of novel agents in brain cancer at UCLH and on a national scale.
 
Additionally, he holds the role of the clinical lead within Datrix, a European Consortium focused on advancing next-generation targeted hyperthermic cancer treatment for glioblastoma through multidisciplinary collaboration.

View Profile

Overall assessment of their patients


  • Related procedures
  • Mouth cancer
    Prostate cancer
    Human papillomavirus (HPV)
    Human papillomavirus vaccine (HPV)
    Breast cancer
    Brain tumour
    Testicular cancer
    Thyroid cancer
    Adrenal glands cancer
    Doppler Ultrasound
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.